A 3-year-old boy from rural Maharashtra presents with progressive weakness, developmental delay, and recurrent infections over 6 months. On examination, he has hepatomegaly, muscle hypotonia, and developmental quotient of 45. Serum lactate is elevated at 8 mmol/L (normal <2), and pyruvate is 0.4 mmol/L. Muscle biopsy shows ragged-red fibres on Gomori trichrome stain. MRI brain reveals basal ganglia involvement. Which complex of the electron transport chain is most likely defective in this patient?

Explanation

## Clinical Diagnosis: Mitochondrial Cytopathy (MELAS or MERRF Phenotype) ### Key Clinical Features **Key Point:** The combination of elevated lactate with normal-to-low pyruvate indicates impaired aerobic metabolism and reliance on anaerobic glycolysis — a hallmark of mitochondrial respiratory chain dysfunction. **High-Yield:** Ragged-red fibres on muscle biopsy are pathognomonic for mitochondrial myopathy and reflect accumulation of abnormal mitochondria at the muscle fibre periphery. ### Why Complex I? 1. **Lactate-Pyruvate Ratio Analysis** - Elevated lactate with low pyruvate → **lactate/pyruvate ratio >> 20** (normal <10) - This pattern reflects impaired NADH oxidation and shunting of pyruvate to lactate via LDH - Complex I defects prevent NADH from donating electrons, causing NADH accumulation and lactate overproduction 2. **Complex I Deficiency Epidemiology** - Accounts for ~30% of mitochondrial respiratory chain disorders - Most common cause of neonatal/early childhood mitochondrial disease - Presents with Leigh syndrome, MELAS, or MERRF phenotypes 3. **Biochemical Mechanism** - NADH cannot be oxidized → NAD^+^ becomes depleted - Glycolysis stalls (requires NAD^+^) - Pyruvate shunted to lactate via lactate dehydrogenase - ATP production severely impaired (loss of Complex I + downstream complexes) ### Differential Considerations | Complex | Lactate/Pyruvate | Typical Presentation | Key Distinguisher | |---------|------------------|----------------------|-------------------| | **Complex I** | **Very high (>>20)** | **Early-onset myopathy, Leigh, MELAS** | **Most common mitochondrial disorder** | | Complex II | Normal/mildly ↑ | Leigh syndrome (rare), Cardiomyopathy | Succinate dehydrogenase; also TCA enzyme | | Complex III | Moderately ↑ | MELAS, myopathy, exercise intolerance | Cytochrome b mutations | | Complex IV | Moderately ↑ | Leigh, infantile cardiomyopathy | COX deficiency; seizures prominent | **Clinical Pearl:** Complex II defects are rare because Complex II is dual-function (both ETC and TCA cycle); complete loss is usually embryonic lethal. Complex IV (COX) deficiency typically presents with seizures and cardiomyopathy as prominent features. ### Supporting Evidence in This Case - **Age of onset:** 3 years (Complex I defects often present in infancy–early childhood) - **Developmental delay + basal ganglia involvement:** Consistent with Leigh-like phenotype (Complex I most common) - **Hepatomegaly + myopathy:** Multisystem involvement typical of Complex I deficiency - **Ragged-red fibres:** Non-specific but universal in mitochondrial myopathies **High-Yield:** The **elevated lactate with depressed pyruvate** is the biochemical signature of Complex I deficiency — this is the single most discriminating lab finding in mitochondrial disease diagnosis.